

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 8.70450562 |
| 2 | translational termination (GO:0006415) | 8.37177617 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 7.14425138 |
| 4 | translational elongation (GO:0006414) | 7.05431324 |
| 5 | protein targeting to ER (GO:0045047) | 7.02967560 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 6.97207296 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 6.80149670 |
| 8 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.70755546 |
| 9 | protein localization to endoplasmic reticulum (GO:0070972) | 6.53289672 |
| 10 | viral life cycle (GO:0019058) | 6.51723819 |
| 11 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.41455424 |
| 12 | cellular protein complex disassembly (GO:0043624) | 6.39846646 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 6.24196373 |
| 14 | ribosomal large subunit biogenesis (GO:0042273) | 6.22048688 |
| 15 | translational initiation (GO:0006413) | 6.11076408 |
| 16 | protein complex disassembly (GO:0043241) | 5.60251529 |
| 17 | macromolecular complex disassembly (GO:0032984) | 5.20852176 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 5.18598776 |
| 19 | protein targeting to membrane (GO:0006612) | 4.72186195 |
| 20 | ncRNA 3-end processing (GO:0043628) | 4.51625318 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.41737253 |
| 22 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.37621919 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.34024002 |
| 24 | mRNA catabolic process (GO:0006402) | 4.16679219 |
| 25 | translation (GO:0006412) | 4.06660243 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.01104150 |
| 27 | negative regulation of cell killing (GO:0031342) | 4.01104150 |
| 28 | DNA deamination (GO:0045006) | 3.97094509 |
| 29 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.94521617 |
| 30 | RNA catabolic process (GO:0006401) | 3.94023568 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88135010 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.87581334 |
| 33 | response to peptidoglycan (GO:0032494) | 3.87459012 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86197343 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86197343 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86197343 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.86197343 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86197343 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.86197343 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.65600105 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.64672075 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63556379 |
| 43 | nuclear envelope reassembly (GO:0031468) | 3.60235144 |
| 44 | mitotic nuclear envelope reassembly (GO:0007084) | 3.60235144 |
| 45 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.58361277 |
| 46 | adenosine receptor signaling pathway (GO:0001973) | 3.58173943 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34292704 |
| 48 | modulation by virus of host process (GO:0019054) | 3.31511552 |
| 49 | negative regulation of RNA splicing (GO:0033119) | 3.26882356 |
| 50 | lipoxygenase pathway (GO:0019372) | 3.23298363 |
| 51 | mannose metabolic process (GO:0006013) | 3.20767341 |
| 52 | tooth mineralization (GO:0034505) | 3.19205104 |
| 53 | DNA replication checkpoint (GO:0000076) | 3.14324447 |
| 54 | detection of bacterium (GO:0016045) | 3.13648361 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 3.13630455 |
| 56 | tolerance induction (GO:0002507) | 3.11374447 |
| 57 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.11352762 |
| 58 | modulation by symbiont of host cellular process (GO:0044068) | 3.10701465 |
| 59 | detection of other organism (GO:0098543) | 3.09316051 |
| 60 | rRNA processing (GO:0006364) | 3.09251885 |
| 61 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.06371154 |
| 62 | establishment of protein localization to membrane (GO:0090150) | 3.04920597 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03049384 |
| 64 | leukocyte aggregation (GO:0070486) | 3.02905169 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.02536795 |
| 66 | GDP-mannose metabolic process (GO:0019673) | 3.01252709 |
| 67 | heme biosynthetic process (GO:0006783) | 3.00075266 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 2.99988311 |
| 69 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.98695266 |
| 70 | spliceosomal snRNP assembly (GO:0000387) | 2.98203730 |
| 71 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.98019553 |
| 72 | rRNA metabolic process (GO:0016072) | 2.97998951 |
| 73 | tetrahydrofolate metabolic process (GO:0046653) | 2.97108769 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96214590 |
| 75 | glycine metabolic process (GO:0006544) | 2.94861799 |
| 76 | positive regulation of T cell apoptotic process (GO:0070234) | 2.92076179 |
| 77 | maternal placenta development (GO:0001893) | 2.92011300 |
| 78 | DNA strand elongation (GO:0022616) | 2.90222376 |
| 79 | protein targeting (GO:0006605) | 2.87328017 |
| 80 | response to muramyl dipeptide (GO:0032495) | 2.86200147 |
| 81 | establishment of protein localization to organelle (GO:0072594) | 2.86166381 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.84783018 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84554135 |
| 84 | DNA replication initiation (GO:0006270) | 2.81193413 |
| 85 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79786192 |
| 86 | spliceosomal complex assembly (GO:0000245) | 2.79688783 |
| 87 | cellular component biogenesis (GO:0044085) | 2.77302026 |
| 88 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76203147 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76096143 |
| 90 | response to host immune response (GO:0052572) | 2.76096143 |
| 91 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76069814 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 2.76027084 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75587740 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75578875 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75578875 |
| 96 | regulation of protein heterodimerization activity (GO:0043497) | 2.75154224 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73998839 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.72986604 |
| 99 | UV protection (GO:0009650) | 2.72036640 |
| 100 | regulation of mitotic spindle organization (GO:0060236) | 2.71751765 |
| 101 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.70507992 |
| 102 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.70407969 |
| 103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69788753 |
| 104 | response to host (GO:0075136) | 2.69788753 |
| 105 | response to host defenses (GO:0052200) | 2.69788753 |
| 106 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69634460 |
| 107 | positive regulation of histone deacetylation (GO:0031065) | 2.69090151 |
| 108 | protein localization to chromosome, centromeric region (GO:0071459) | 2.67022860 |
| 109 | cellular response to virus (GO:0098586) | 2.66903563 |
| 110 | skin morphogenesis (GO:0043589) | 2.64105853 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.63197428 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.62307621 |
| 113 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.61644973 |
| 114 | detection of external biotic stimulus (GO:0098581) | 2.61194860 |
| 115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60970813 |
| 116 | myeloid cell activation involved in immune response (GO:0002275) | 2.60535097 |
| 117 | negative regulation of phagocytosis (GO:0050765) | 2.60267309 |
| 118 | apoptotic process involved in morphogenesis (GO:0060561) | 2.59977577 |
| 119 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.58596804 |
| 120 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.58583847 |
| 121 | telomere maintenance via recombination (GO:0000722) | 2.57348448 |
| 122 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.56090447 |
| 123 | L-serine metabolic process (GO:0006563) | 2.55701639 |
| 124 | defense response to protozoan (GO:0042832) | 2.55609643 |
| 125 | negative regulation of mRNA processing (GO:0050686) | 2.55222836 |
| 126 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.55032842 |
| 127 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.54425115 |
| 128 | negative regulation of innate immune response (GO:0045824) | 2.54403469 |
| 129 | positive thymic T cell selection (GO:0045059) | 2.54137655 |
| 130 | detection of biotic stimulus (GO:0009595) | 2.53241393 |
| 131 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52566505 |
| 132 | regulation of cell aging (GO:0090342) | 2.51344781 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.51110497 |
| 134 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.50014290 |
| 135 | pentose-phosphate shunt (GO:0006098) | 2.49967199 |
| 136 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.49328828 |
| 137 | serine family amino acid biosynthetic process (GO:0009070) | 2.48682547 |
| 138 | regulation of tumor necrosis factor production (GO:0032680) | 2.48530410 |
| 139 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.48525766 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.48106387 |
| 141 | barbed-end actin filament capping (GO:0051016) | 2.47688900 |
| 142 | amino sugar catabolic process (GO:0046348) | 2.46920735 |
| 143 | DNA unwinding involved in DNA replication (GO:0006268) | 2.46494519 |
| 144 | mitotic nuclear envelope disassembly (GO:0007077) | 2.45585625 |
| 145 | respiratory burst (GO:0045730) | 2.44955473 |
| 146 | regulation of necrotic cell death (GO:0010939) | 2.44786361 |
| 147 | mitotic recombination (GO:0006312) | 2.44502517 |
| 148 | negative regulation of interleukin-6 production (GO:0032715) | 2.44315970 |
| 149 | response to protozoan (GO:0001562) | 2.43717500 |
| 150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.43384796 |
| 151 | actin nucleation (GO:0045010) | 2.43287405 |
| 152 | protein localization to kinetochore (GO:0034501) | 2.43274441 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40541091 |
| 154 | folic acid-containing compound metabolic process (GO:0006760) | 2.37298018 |
| 155 | cellular component disassembly (GO:0022411) | 2.36761989 |
| 156 | RNA stabilization (GO:0043489) | 2.35822127 |
| 157 | mRNA stabilization (GO:0048255) | 2.35822127 |
| 158 | pattern specification involved in kidney development (GO:0061004) | 2.32077557 |
| 159 | intra-S DNA damage checkpoint (GO:0031573) | 2.31154714 |
| 160 | heme metabolic process (GO:0042168) | 2.30926500 |
| 161 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.30518911 |
| 162 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.30310915 |
| 163 | regulation of spindle organization (GO:0090224) | 2.29171174 |
| 164 | termination of RNA polymerase II transcription (GO:0006369) | 2.28900104 |
| 165 | pteridine-containing compound metabolic process (GO:0042558) | 2.28244698 |
| 166 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.27498656 |
| 167 | negative regulation of cell aging (GO:0090344) | 2.27083451 |
| 168 | endothelium development (GO:0003158) | 2.24996854 |
| 169 | telomere maintenance via telomere lengthening (GO:0010833) | 2.23332091 |
| 170 | folic acid metabolic process (GO:0046655) | 2.22432208 |
| 171 | protein localization to membrane (GO:0072657) | 2.22191143 |
| 172 | negative regulation of mRNA metabolic process (GO:1903312) | 2.22005652 |
| 173 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.20605045 |
| 174 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.20605045 |
| 175 | nuclear envelope disassembly (GO:0051081) | 2.20151537 |
| 176 | membrane disassembly (GO:0030397) | 2.20151537 |
| 177 | pentose metabolic process (GO:0019321) | 2.18067645 |
| 178 | DNA damage response, detection of DNA damage (GO:0042769) | 2.17155402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.38354275 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.71697292 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.67130838 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.35832230 |
| 5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76367289 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.71203558 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57242259 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.42946912 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.42315294 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41728818 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.35195131 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.34760000 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.27078315 |
| 14 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.26143182 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21272324 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13280977 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06255242 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.05551700 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01038462 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99808622 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98874161 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96951295 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93911071 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93688915 |
| 25 | P68_20966046_ChIP-Seq_HELA_Human | 1.92696091 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.92595749 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89221837 |
| 28 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.86169958 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79245963 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74095931 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.70623843 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69949080 |
| 33 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.68188720 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.67975888 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66463583 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66014088 |
| 37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65813960 |
| 38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.65205405 |
| 39 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.65177711 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64147011 |
| 41 | * MAF_26560356_Chip-Seq_TH1_Human | 1.62547449 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60814905 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57229192 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54968422 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.53339025 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52022319 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51160314 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49837358 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49363221 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48391185 |
| 51 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48064211 |
| 52 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47369739 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47034233 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46796508 |
| 55 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.46470889 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.45331456 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43394363 |
| 58 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42287107 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40980033 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40624510 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39966625 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39380384 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37945638 |
| 64 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37675117 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37481523 |
| 66 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36531857 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35227834 |
| 68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35200620 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34884706 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34512985 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34231357 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34170193 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34106375 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33964464 |
| 75 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.33440717 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32880209 |
| 77 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32379988 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31612620 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30668314 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29229479 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28653507 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28154808 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28095386 |
| 84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27678540 |
| 85 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27218825 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27068892 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26901779 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26843151 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26679160 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25800776 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25522193 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25317245 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24794596 |
| 94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24691907 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24192028 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23795051 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23716085 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23287606 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22989976 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22719278 |
| 101 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22430974 |
| 102 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20461064 |
| 103 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19963860 |
| 104 | SA1_27219007_Chip-Seq_Bcells_Human | 1.19594449 |
| 105 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18714431 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18320044 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18172289 |
| 108 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17899821 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17468241 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.16824184 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16441665 |
| 112 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15281205 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15086330 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14815437 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13461269 |
| 116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12490927 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12211847 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11945273 |
| 119 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11648946 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11465016 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11458714 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.10921782 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10872421 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10802930 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10717385 |
| 126 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10476599 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10128198 |
| 128 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.09929212 |
| 129 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09407656 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09273806 |
| 131 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09100092 |
| 132 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09043869 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.08956805 |
| 134 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07838826 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07433140 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06124176 |
| 137 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05630318 |
| 138 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05026988 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04799598 |
| 140 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04214869 |
| 141 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04120014 |
| 142 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.03992112 |
| 143 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03727412 |
| 144 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01870890 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01708269 |
| 146 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01524567 |
| 147 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00113401 |
| 148 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00062691 |
| 149 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99558069 |
| 150 | MYB_26560356_Chip-Seq_TH2_Human | 0.99418403 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98264844 |
| 152 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97712208 |
| 153 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.97358106 |
| 154 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96350465 |
| 155 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95275306 |
| 156 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93954290 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93802453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.90711078 |
| 2 | MP0003303_peritoneal_inflammation | 4.68917367 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.96767576 |
| 4 | MP0005464_abnormal_platelet_physiology | 2.90459236 |
| 5 | MP0003724_increased_susceptibility_to | 2.63431095 |
| 6 | MP0004510_myositis | 2.52587290 |
| 7 | MP0005451_abnormal_body_composition | 2.47973168 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.34108477 |
| 9 | MP0004185_abnormal_adipocyte_glucose | 2.20333001 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.18762687 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.10094520 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.03750048 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.02281748 |
| 14 | MP0003111_abnormal_nucleus_morphology | 1.94425160 |
| 15 | MP0004858_abnormal_nervous_system | 1.93934779 |
| 16 | MP0008260_abnormal_autophagy | 1.92313121 |
| 17 | MP0003436_decreased_susceptibility_to | 1.92164079 |
| 18 | * MP0004957_abnormal_blastocyst_morpholog | 1.89641877 |
| 19 | MP0000490_abnormal_crypts_of | 1.87530739 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.85875287 |
| 21 | MP0000678_abnormal_parathyroid_gland | 1.81894366 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.72064324 |
| 23 | MP0008007_abnormal_cellular_replicative | 1.71800567 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.65075425 |
| 25 | MP0003077_abnormal_cell_cycle | 1.64353109 |
| 26 | MP0000685_abnormal_immune_system | 1.62580188 |
| 27 | MP0010030_abnormal_orbit_morphology | 1.62316342 |
| 28 | MP0008004_abnormal_stomach_pH | 1.59907282 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.57151498 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.56464032 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.56299386 |
| 32 | MP0005083_abnormal_biliary_tract | 1.54498651 |
| 33 | MP0003828_pulmonary_edema | 1.51798107 |
| 34 | MP0009053_abnormal_anal_canal | 1.48839235 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.47296039 |
| 36 | MP0006082_CNS_inflammation | 1.46310470 |
| 37 | MP0001800_abnormal_humoral_immune | 1.42824032 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.37291084 |
| 39 | MP0002398_abnormal_bone_marrow | 1.36336660 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.35185749 |
| 41 | MP0000858_altered_metastatic_potential | 1.35098321 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.33288490 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.30606518 |
| 44 | MP0000343_altered_response_to | 1.28030343 |
| 45 | MP0003879_abnormal_hair_cell | 1.27789915 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.26564413 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.25459353 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.24313357 |
| 49 | MP0001849_ear_inflammation | 1.23961613 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.21633981 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.21633981 |
| 52 | MP0001663_abnormal_digestive_system | 1.20992438 |
| 53 | MP0005025_abnormal_response_to | 1.20672407 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.20349870 |
| 55 | MP0002722_abnormal_immune_system | 1.20228897 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.18942553 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.18160615 |
| 58 | * MP0008932_abnormal_embryonic_tissue | 1.17232860 |
| 59 | MP0002723_abnormal_immune_serum | 1.17091264 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.16764354 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.16760919 |
| 62 | MP0005360_urolithiasis | 1.16440817 |
| 63 | MP0003075_altered_response_to | 1.15878819 |
| 64 | MP0001819_abnormal_immune_cell | 1.14870609 |
| 65 | MP0005387_immune_system_phenotype | 1.14697740 |
| 66 | MP0001790_abnormal_immune_system | 1.14697740 |
| 67 | MP0002405_respiratory_system_inflammati | 1.14459673 |
| 68 | MP0002132_abnormal_respiratory_system | 1.12315599 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.11596057 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.11351404 |
| 71 | MP0004130_abnormal_muscle_cell | 1.10892389 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.10883048 |
| 73 | MP0002429_abnormal_blood_cell | 1.10312509 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.10305626 |
| 75 | MP0003011_delayed_dark_adaptation | 1.09943254 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 1.09499042 |
| 77 | MP0000716_abnormal_immune_system | 1.08569540 |
| 78 | MP0003941_abnormal_skin_development | 1.06505428 |
| 79 | MP0002933_joint_inflammation | 1.06185148 |
| 80 | MP0005174_abnormal_tail_pigmentation | 1.05631474 |
| 81 | MP0005166_decreased_susceptibility_to | 1.05495012 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.02640023 |
| 83 | MP0003566_abnormal_cell_adhesion | 1.02393455 |
| 84 | MP0003136_yellow_coat_color | 1.01772150 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.01058408 |
| 86 | MP0005409_darkened_coat_color | 1.00698057 |
| 87 | MP0001873_stomach_inflammation | 0.98179121 |
| 88 | MP0002249_abnormal_larynx_morphology | 0.96156762 |
| 89 | MP0005671_abnormal_response_to | 0.95967954 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.95097616 |
| 91 | MP0001851_eye_inflammation | 0.93625080 |
| 92 | MP0001730_embryonic_growth_arrest | 0.93148062 |
| 93 | MP0003866_abnormal_defecation | 0.92905387 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.92905268 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.92400170 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.91790356 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.91230205 |
| 98 | MP0009785_altered_susceptibility_to | 0.91128689 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 0.89167765 |
| 100 | MP0009278_abnormal_bone_marrow | 0.89121430 |
| 101 | MP0009764_decreased_sensitivity_to | 0.89072240 |
| 102 | MP0005310_abnormal_salivary_gland | 0.88613786 |
| 103 | MP0000313_abnormal_cell_death | 0.88180766 |
| 104 | * MP0002080_prenatal_lethality | 0.84578930 |
| 105 | MP0001853_heart_inflammation | 0.83545325 |
| 106 | MP0009840_abnormal_foam_cell | 0.83154130 |
| 107 | MP0003091_abnormal_cell_migration | 0.83050929 |
| 108 | MP0005375_adipose_tissue_phenotype | 0.82434565 |
| 109 | MP0003448_altered_tumor_morphology | 0.81221152 |
| 110 | MP0001697_abnormal_embryo_size | 0.81010911 |
| 111 | MP0003279_aneurysm | 0.80341770 |
| 112 | MP0003786_premature_aging | 0.80168770 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.80028157 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.79806690 |
| 115 | MP0000609_abnormal_liver_physiology | 0.79502823 |
| 116 | MP0003186_abnormal_redox_activity | 0.79248835 |
| 117 | MP0004381_abnormal_hair_follicle | 0.77887146 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.77441820 |
| 119 | MP0009672_abnormal_birth_weight | 0.77428192 |
| 120 | MP0001542_abnormal_bone_strength | 0.77393505 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.76919243 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.76622381 |
| 123 | MP0008469_abnormal_protein_level | 0.75751227 |
| 124 | MP0005023_abnormal_wound_healing | 0.75321224 |
| 125 | MP0002419_abnormal_innate_immunity | 0.75318442 |
| 126 | MP0010307_abnormal_tumor_latency | 0.74102494 |
| 127 | MP0005410_abnormal_fertilization | 0.73851712 |
| 128 | MP0002006_tumorigenesis | 0.73255613 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.73166038 |
| 130 | MP0004947_skin_inflammation | 0.72211180 |
| 131 | * MP0005501_abnormal_skin_physiology | 0.72125353 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.71789138 |
| 133 | MP0000249_abnormal_blood_vessel | 0.71363178 |
| 134 | MP0002970_abnormal_white_adipose | 0.70276453 |
| 135 | MP0008874_decreased_physiological_sensi | 0.70025991 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.68860372 |
| 137 | MP0005390_skeleton_phenotype | 0.68811084 |
| 138 | MP0003191_abnormal_cellular_cholesterol | 0.68254894 |
| 139 | MP0000598_abnormal_liver_morphology | 0.66147923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 6.13923392 |
| 2 | Macrocytic anemia (HP:0001972) | 4.88039673 |
| 3 | Abnormal hemoglobin (HP:0011902) | 4.75165544 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.69998905 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.66089436 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.42350280 |
| 7 | Pallor (HP:0000980) | 4.23664026 |
| 8 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 4.19114336 |
| 9 | Purpura (HP:0000979) | 4.05032447 |
| 10 | Petechiae (HP:0000967) | 4.04753844 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.96304490 |
| 12 | Premature rupture of membranes (HP:0001788) | 3.92346253 |
| 13 | Concave nail (HP:0001598) | 3.91543230 |
| 14 | Achilles tendon contracture (HP:0001771) | 3.87695459 |
| 15 | Abnormality of the Achilles tendon (HP:0005109) | 3.69267730 |
| 16 | Hypertensive crisis (HP:0100735) | 3.02985628 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.01151988 |
| 18 | Thrombocytosis (HP:0001894) | 2.97238492 |
| 19 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95471775 |
| 20 | Abnormality of reticulocytes (HP:0004312) | 2.93304773 |
| 21 | Protrusio acetabuli (HP:0003179) | 2.88716510 |
| 22 | Colitis (HP:0002583) | 2.88628169 |
| 23 | Thin bony cortex (HP:0002753) | 2.81609678 |
| 24 | Recurrent skin infections (HP:0001581) | 2.74786378 |
| 25 | Myositis (HP:0100614) | 2.74011186 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 2.68301226 |
| 27 | Trismus (HP:0000211) | 2.67928853 |
| 28 | Emphysema (HP:0002097) | 2.66143707 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 2.65056342 |
| 30 | Sparse lateral eyebrow (HP:0005338) | 2.63769310 |
| 31 | Multiple enchondromatosis (HP:0005701) | 2.63088942 |
| 32 | Myocardial infarction (HP:0001658) | 2.58547411 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.56205133 |
| 34 | Progressive muscle weakness (HP:0003323) | 2.52821508 |
| 35 | Hyperthyroidism (HP:0000836) | 2.50038199 |
| 36 | Meningitis (HP:0001287) | 2.47539157 |
| 37 | Increased IgE level (HP:0003212) | 2.46840913 |
| 38 | Testicular atrophy (HP:0000029) | 2.46395641 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44551608 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40704336 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40002112 |
| 42 | Obstructive lung disease (HP:0006536) | 2.40002112 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.37864833 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36548807 |
| 45 | Seborrheic dermatitis (HP:0001051) | 2.31880693 |
| 46 | Stomatitis (HP:0010280) | 2.30229883 |
| 47 | Gingivitis (HP:0000230) | 2.29438669 |
| 48 | Menorrhagia (HP:0000132) | 2.27721147 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.26546499 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25192041 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25192041 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25192041 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.21643174 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.19928488 |
| 55 | Increased serum ferritin (HP:0003281) | 2.19892233 |
| 56 | Bulbar palsy (HP:0001283) | 2.19752219 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18213932 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18213932 |
| 59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.16543937 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16221953 |
| 61 | Truncus arteriosus (HP:0001660) | 2.16138407 |
| 62 | Hypochromic anemia (HP:0001931) | 2.15073695 |
| 63 | Abnormality of complement system (HP:0005339) | 2.14352576 |
| 64 | Polygenic inheritance (HP:0010982) | 2.13666303 |
| 65 | Secondary amenorrhea (HP:0000869) | 2.13539570 |
| 66 | Genu recurvatum (HP:0002816) | 2.12955770 |
| 67 | Increased density of long bones (HP:0006392) | 2.12833569 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12561667 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12561667 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.11812032 |
| 71 | Entropion (HP:0000621) | 2.11401105 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11219431 |
| 73 | Gingival bleeding (HP:0000225) | 2.09241526 |
| 74 | Orchitis (HP:0100796) | 2.08001104 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07889602 |
| 76 | Hypertriglyceridemia (HP:0002155) | 2.06960664 |
| 77 | Exertional dyspnea (HP:0002875) | 2.06143710 |
| 78 | Microcytic anemia (HP:0001935) | 2.05105918 |
| 79 | Pustule (HP:0200039) | 2.04853523 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.04376765 |
| 81 | Oral leukoplakia (HP:0002745) | 2.03709752 |
| 82 | Myopathic facies (HP:0002058) | 2.03174945 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.02847754 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.02311799 |
| 85 | Basal cell carcinoma (HP:0002671) | 2.02092481 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.01815559 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.01285215 |
| 88 | Verrucae (HP:0200043) | 2.00707625 |
| 89 | Papilloma (HP:0012740) | 2.00707625 |
| 90 | Polycythemia (HP:0001901) | 2.00422733 |
| 91 | Vasculitis (HP:0002633) | 2.00371873 |
| 92 | Cellulitis (HP:0100658) | 2.00324434 |
| 93 | Rhabdomyosarcoma (HP:0002859) | 1.98284405 |
| 94 | Abnormal platelet function (HP:0011869) | 1.97502419 |
| 95 | Impaired platelet aggregation (HP:0003540) | 1.97502419 |
| 96 | Depressed nasal ridge (HP:0000457) | 1.96952740 |
| 97 | Lymphopenia (HP:0001888) | 1.96565117 |
| 98 | Axonal loss (HP:0003447) | 1.96046396 |
| 99 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95829213 |
| 100 | Multiple lipomas (HP:0001012) | 1.95218112 |
| 101 | Joint stiffness (HP:0001387) | 1.95007239 |
| 102 | Deep palmar crease (HP:0006191) | 1.94477235 |
| 103 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.93937675 |
| 104 | Breast hypoplasia (HP:0003187) | 1.92421991 |
| 105 | Redundant skin (HP:0001582) | 1.92297732 |
| 106 | Double outlet right ventricle (HP:0001719) | 1.92217031 |
| 107 | Congenital malformation of the right heart (HP:0011723) | 1.92217031 |
| 108 | Increased intramyocellular lipid droplets (HP:0012240) | 1.91983117 |
| 109 | Biconcave vertebral bodies (HP:0004586) | 1.91895997 |
| 110 | Prolonged bleeding time (HP:0003010) | 1.91893897 |
| 111 | Hyperphosphaturia (HP:0003109) | 1.90650701 |
| 112 | Triphalangeal thumb (HP:0001199) | 1.90381926 |
| 113 | Abnormal platelet volume (HP:0011876) | 1.89778290 |
| 114 | Malnutrition (HP:0004395) | 1.89289458 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 1.86138829 |
| 116 | Angiofibromas (HP:0010615) | 1.86027475 |
| 117 | Adenoma sebaceum (HP:0009720) | 1.86027475 |
| 118 | Gastrointestinal dysmotility (HP:0002579) | 1.85140826 |
| 119 | Increased IgM level (HP:0003496) | 1.85102138 |
| 120 | Nasal polyposis (HP:0100582) | 1.84164955 |
| 121 | Down-sloping shoulders (HP:0200021) | 1.83255197 |
| 122 | Woolly hair (HP:0002224) | 1.82366892 |
| 123 | Unilateral renal agenesis (HP:0000122) | 1.81783840 |
| 124 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81168090 |
| 125 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81111751 |
| 126 | Encephalitis (HP:0002383) | 1.81070308 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 1.79058352 |
| 128 | Limb-girdle muscle atrophy (HP:0003797) | 1.77636712 |
| 129 | Recurrent viral infections (HP:0004429) | 1.76557624 |
| 130 | Increased mean platelet volume (HP:0011877) | 1.75907074 |
| 131 | Atelectasis (HP:0100750) | 1.75835591 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.75640849 |
| 133 | Migraine (HP:0002076) | 1.75628841 |
| 134 | Gastrointestinal inflammation (HP:0004386) | 1.75382557 |
| 135 | Abnormality of T cells (HP:0002843) | 1.74518588 |
| 136 | Late onset (HP:0003584) | 1.74430986 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.74230256 |
| 138 | Porencephaly (HP:0002132) | 1.74073960 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.73818764 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.73211364 |
| 141 | Large earlobe (HP:0009748) | 1.73010825 |
| 142 | Recurrent abscess formation (HP:0002722) | 1.72923531 |
| 143 | Rough bone trabeculation (HP:0100670) | 1.72726546 |
| 144 | Ragged-red muscle fibers (HP:0003200) | 1.72424972 |
| 145 | Hypercortisolism (HP:0001578) | 1.72127003 |
| 146 | Chest pain (HP:0100749) | 1.71206165 |
| 147 | Abnormal pupillary function (HP:0007686) | 1.69525335 |
| 148 | Peritonitis (HP:0002586) | 1.68735452 |
| 149 | Mitral regurgitation (HP:0001653) | 1.68673032 |
| 150 | Epistaxis (HP:0000421) | 1.68079190 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.67741749 |
| 152 | Rectal prolapse (HP:0002035) | 1.66618283 |
| 153 | Mitral valve prolapse (HP:0001634) | 1.66370219 |
| 154 | Thick lower lip vermilion (HP:0000179) | 1.65240095 |
| 155 | Hypoparathyroidism (HP:0000829) | 1.64594234 |
| 156 | Abnormality of dental color (HP:0011073) | 1.63959263 |
| 157 | Urticaria (HP:0001025) | 1.63928090 |
| 158 | Soft skin (HP:0000977) | 1.61475892 |
| 159 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.61058541 |
| 160 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.61054208 |
| 161 | Xanthomatosis (HP:0000991) | 1.60470784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 6.60241198 |
| 2 | NME2 | 3.67556047 |
| 3 | EIF2AK1 | 3.56869350 |
| 4 | PRPF4B | 2.98897543 |
| 5 | RIPK4 | 2.83981102 |
| 6 | TESK2 | 2.72528339 |
| 7 | SMG1 | 2.71446663 |
| 8 | TRIB3 | 2.64465484 |
| 9 | BLK | 2.58833791 |
| 10 | PKN2 | 2.46176453 |
| 11 | NEK9 | 2.44532687 |
| 12 | PIM2 | 2.34205587 |
| 13 | FES | 2.24162609 |
| 14 | MAP3K10 | 2.18942204 |
| 15 | MAP4K1 | 2.15836673 |
| 16 | BUB1 | 2.03209597 |
| 17 | ARAF | 1.98639662 |
| 18 | SIK1 | 1.95961017 |
| 19 | TAOK2 | 1.87497046 |
| 20 | MAP3K13 | 1.79792367 |
| 21 | MAP3K11 | 1.59551754 |
| 22 | MKNK2 | 1.58936984 |
| 23 | CSK | 1.58440019 |
| 24 | EEF2K | 1.50196280 |
| 25 | FLT3 | 1.49083608 |
| 26 | MAP3K1 | 1.44126855 |
| 27 | DMPK | 1.42675071 |
| 28 | DYRK1B | 1.37552819 |
| 29 | ICK | 1.36044748 |
| 30 | TBK1 | 1.33971041 |
| 31 | NEK2 | 1.31623668 |
| 32 | DYRK3 | 1.28486860 |
| 33 | ERN1 | 1.23881347 |
| 34 | WEE1 | 1.23262775 |
| 35 | LRRK2 | 1.19506700 |
| 36 | ZAP70 | 1.18082684 |
| 37 | RPS6KA4 | 1.17895641 |
| 38 | STK10 | 1.15682843 |
| 39 | PDPK1 | 1.14040890 |
| 40 | VRK2 | 1.11991738 |
| 41 | IRAK4 | 1.10238537 |
| 42 | TNK2 | 1.07894300 |
| 43 | MAP3K3 | 1.06157574 |
| 44 | MARK2 | 1.05911250 |
| 45 | PIM1 | 1.04446974 |
| 46 | SCYL2 | 1.04060800 |
| 47 | DAPK3 | 1.03551670 |
| 48 | BCKDK | 1.02011105 |
| 49 | CDK7 | 1.01137988 |
| 50 | CDK9 | 0.99852593 |
| 51 | BRAF | 0.99707202 |
| 52 | TESK1 | 0.99315418 |
| 53 | MAP3K8 | 0.99284289 |
| 54 | GRK6 | 0.98373100 |
| 55 | CDC7 | 0.97907036 |
| 56 | IRAK1 | 0.97906191 |
| 57 | MAPK12 | 0.93921727 |
| 58 | SRPK1 | 0.92544396 |
| 59 | IRAK3 | 0.92316152 |
| 60 | MOS | 0.91006419 |
| 61 | TYK2 | 0.90512527 |
| 62 | RPS6KC1 | 0.89911155 |
| 63 | RPS6KL1 | 0.89911155 |
| 64 | CLK1 | 0.89663140 |
| 65 | PAK4 | 0.88670721 |
| 66 | CDK6 | 0.87852052 |
| 67 | CDK4 | 0.87826484 |
| 68 | ALK | 0.86474499 |
| 69 | CDC42BPA | 0.86205096 |
| 70 | KSR2 | 0.85545421 |
| 71 | ILK | 0.84665325 |
| 72 | PRKD2 | 0.81685761 |
| 73 | BTK | 0.78792440 |
| 74 | PRKD3 | 0.78543129 |
| 75 | TEC | 0.77824752 |
| 76 | MAPK11 | 0.77341577 |
| 77 | MAPK15 | 0.76302350 |
| 78 | KDR | 0.76148216 |
| 79 | RPS6KA6 | 0.73932405 |
| 80 | AURKB | 0.73675601 |
| 81 | PDK1 | 0.73492773 |
| 82 | IKBKE | 0.73125092 |
| 83 | EPHB1 | 0.72904482 |
| 84 | IKBKB | 0.72088298 |
| 85 | NLK | 0.71818363 |
| 86 | CDK19 | 0.71443028 |
| 87 | SIK2 | 0.70625622 |
| 88 | FER | 0.69481910 |
| 89 | LCK | 0.69374359 |
| 90 | TTK | 0.68230447 |
| 91 | TAOK1 | 0.68070934 |
| 92 | HIPK2 | 0.66950752 |
| 93 | MKNK1 | 0.66603017 |
| 94 | RPS6KB2 | 0.66062853 |
| 95 | JAK3 | 0.65014224 |
| 96 | MAP3K14 | 0.64097110 |
| 97 | MAP2K2 | 0.63030184 |
| 98 | PLK1 | 0.62424141 |
| 99 | RPS6KA2 | 0.62223856 |
| 100 | FGFR4 | 0.61491092 |
| 101 | CDK8 | 0.60347270 |
| 102 | AURKA | 0.60255042 |
| 103 | LYN | 0.57660396 |
| 104 | STK16 | 0.55661732 |
| 105 | STK4 | 0.53160663 |
| 106 | JAK2 | 0.52316602 |
| 107 | EPHB2 | 0.52280168 |
| 108 | NME1 | 0.50325986 |
| 109 | LIMK1 | 0.49986325 |
| 110 | ABL2 | 0.49345009 |
| 111 | HCK | 0.47607244 |
| 112 | IRAK2 | 0.47174449 |
| 113 | STK11 | 0.46243091 |
| 114 | MTOR | 0.45582059 |
| 115 | RPS6KA5 | 0.44555142 |
| 116 | MAPK7 | 0.43175286 |
| 117 | PTK6 | 0.43172865 |
| 118 | PRKG2 | 0.42764961 |
| 119 | CSF1R | 0.42517760 |
| 120 | MELK | 0.42318437 |
| 121 | MYLK | 0.41538031 |
| 122 | SIK3 | 0.41333525 |
| 123 | EIF2AK3 | 0.41050868 |
| 124 | VRK1 | 0.40999361 |
| 125 | TXK | 0.40151730 |
| 126 | CSNK2A2 | 0.40028068 |
| 127 | PAK1 | 0.39763076 |
| 128 | MAPK4 | 0.38310300 |
| 129 | BMX | 0.38015600 |
| 130 | TGFBR2 | 0.36547865 |
| 131 | KIT | 0.36130989 |
| 132 | MAPKAPK2 | 0.35796798 |
| 133 | TTN | 0.35748332 |
| 134 | MAP2K6 | 0.35162330 |
| 135 | CDK12 | 0.34138169 |
| 136 | FGR | 0.34054592 |
| 137 | CSNK2A1 | 0.33319912 |
| 138 | MAP2K3 | 0.32726814 |
| 139 | CHEK2 | 0.32534512 |
| 140 | SYK | 0.31745207 |
| 141 | MARK3 | 0.27146886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.31858122 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.36537294 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.27028408 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.00445988 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 2.24813222 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.13268320 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.04072705 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98192082 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96881946 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.92234658 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.86065480 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.81296348 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72482102 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.66776367 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.65590028 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64348172 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.63321628 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57678337 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.54453694 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.53178852 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52759776 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.50054025 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49801319 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43174160 |
| 25 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.40991581 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.40551365 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40481232 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39107106 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39033465 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.33758408 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21756225 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21192676 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19510168 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17368535 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16286404 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16232201 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.14156118 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13452514 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11956005 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11056664 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10384563 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.08943596 |
| 43 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.07522392 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07495478 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05274093 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05046270 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02739976 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00830183 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00533917 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99228627 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96599629 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.95837908 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.94422934 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94284003 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90448133 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89269226 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87924464 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87721588 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85938860 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83727028 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81746237 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.81611201 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81154315 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.81146593 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.79694100 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.77836518 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77744954 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77734977 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77237964 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76589436 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.76303255 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.74494262 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74170224 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.73426477 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73291739 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72805150 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72592669 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72400343 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70289047 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70152164 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69862830 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.69560541 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66500910 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66492131 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65651972 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64415305 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64073921 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63960039 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63611816 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63407985 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63367053 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63192655 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62763713 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.62480102 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.61839005 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60345044 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59505555 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59439791 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59061935 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58961782 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58885629 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58820179 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58391198 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57727111 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55824455 |
| 106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55705652 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54700822 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54459809 |
| 109 | Proteasome_Homo sapiens_hsa03050 | 0.52904795 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52564588 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.51965044 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50668360 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50485726 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50374495 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50229975 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49985911 |
| 117 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49264180 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49238436 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49009787 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.48692082 |
| 121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47648867 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47407317 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47202947 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.46233779 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45398906 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45047773 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44972475 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44763039 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43329717 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42691281 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42674504 |
| 132 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42186046 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41602819 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.41053251 |
| 135 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41007383 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40940408 |
| 137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39315035 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37210547 |
| 139 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36233922 |
| 140 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36045963 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.35897326 |
| 142 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35199011 |
| 143 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34748473 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34292312 |
| 145 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34223226 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.34163011 |
| 147 | Melanoma_Homo sapiens_hsa05218 | 0.34041220 |
| 148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33779848 |
| 149 | Influenza A_Homo sapiens_hsa05164 | 0.33325493 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32604780 |
| 151 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31693587 |
| 152 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31390078 |

